Cytomegalovirus in liver transplant recipients: there are many ways to Rome

Liver Transpl. 2006 Feb;12(2):326. doi: 10.1002/lt.20675.
No abstract available

Publication types

  • Comment
  • Comparative Study
  • Letter

MeSH terms

  • Antiviral Agents / administration & dosage*
  • Cytomegalovirus Infections / drug therapy
  • Cytomegalovirus Infections / mortality
  • Cytomegalovirus Infections / prevention & control*
  • DNA, Viral / analysis
  • Female
  • Follow-Up Studies
  • Graft Rejection / virology
  • Graft Survival
  • Humans
  • Immunocompromised Host*
  • Incidence
  • Liver Failure / diagnosis
  • Liver Failure / mortality
  • Liver Failure / surgery
  • Liver Transplantation / adverse effects*
  • Liver Transplantation / immunology
  • Liver Transplantation / mortality
  • Male
  • Opportunistic Infections / prevention & control*
  • Opportunistic Infections / virology
  • Polymerase Chain Reaction
  • Postoperative Complications / epidemiology
  • Postoperative Complications / virology
  • Primary Prevention / methods
  • Randomized Controlled Trials as Topic
  • Risk Assessment
  • Survival Rate
  • Transplantation Immunology

Substances

  • Antiviral Agents
  • DNA, Viral